Harnessing oncolytic virus-mediated immunity [E-Book] / Volker Schirrmacher ; Philippe Fournier
Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...
Saved in:
Full text |
|
Imprint: |
Lausanne :
Frontiers Media SA,
2015
|
Physical Description: |
1 electronic resource (110 pages) |
Note: |
englisch |
ISBN: |
9782889194506 |
Keywords: |
oncolytic virus ; anti-tumor activity ; tumor-associated antigen ; oncolytic virotherapy ; immunovirotherapy ; immunotherapeutic approaches ; anti-viral response |
Subject (LOC): |
LEADER | 02014nam a2200289uu 4500 | ||
---|---|---|---|
001 | 18596 | ||
008 | 170415s|||| xx o 0 u ||| | | ||
020 | |a 9782889194506 | ||
035 | |a (Sirsi) a661008 | ||
035 | |a a661008 | ||
041 | |a eng | ||
245 | 1 | 0 | |a Harnessing oncolytic virus-mediated immunity |h [E-Book] / |c Volker Schirrmacher ; Philippe Fournier |
264 | 1 | |a Lausanne : |b Frontiers Media SA, |c 2015 |e (DOAB) | |
300 | |a 1 electronic resource (110 pages) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a englisch | ||
520 | |a Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-oncolytic immune response continues to mediate tumor destruction and retards progression of the disease. For a long time, the therapeutic efficacy was thought to depend mainly on the direct viral oncolysis based on their tumor selective replication and killing activities. But the post-oncolytic anti-tumor activity induced by the OV therapy is also a key factor for an efficient therapeutic activity. The topic adresses various strategies how to optimize OVs anti-tumor activity. | ||
650 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
650 | 0 | |a Immunologic diseases. Allergy | |
650 | 0 | |a Medicine (General) | |
653 | |a oncolytic virus ; anti-tumor activity ; tumor-associated antigen ; oncolytic virotherapy ; immunovirotherapy ; immunotherapeutic approaches ; anti-viral response | ||
856 | |u http://journal.frontiersin.org/researchtopic/1613/harnessing-oncolytic-virus-mediated-antitumor-immunity |z Volltext | ||
915 | |a zzwFZJFrontiers | ||
596 | |a 1 | ||
949 | |a XX(661008.1) |w AUTO |c 1 |i 661008-1001 |l ELECTRONIC |m ZB |r N |s Y |t E-BOOK |u 15/5/2017 |x UNKNOWN |z UNKNOWN |1 ONLINE |